Asean

Zoom Leads A Workplace Revolution

Major new brand campaign developed with Colin Jost’s No Notes Productions lampoons bad tech and champions the employees who suffer for it SAN JOSE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) — Today, on behalf of employees everywhere, Zoom announced the

Read More ➜

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older

Read More ➜